O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+16.01%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.4B
AUM Growth
+$11.4B
(+11%)
Cap. Flow
-$84.1M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
148
New
18
Increased
32
Reduced
23
Closed
13
Top Buys
| 1 |
Boston Scientific
BSX
|
$234M |
| 2 |
ACT.PRA
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
|
$105M |
| 3 |
Bristol-Myers Squibb
BMY
|
$77M |
| 4 |
BLUE
bluebird bio
BLUE
|
$66.5M |
| 5 |
Cardinal Health
CAH
|
$57.3M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$188M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$158M |
| 3 |
Merck
MRK
|
$144M |
| 4 |
Biogen
BIIB
|
$122M |
| 5 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$106M |
Sector Composition
| 1 | Healthcare | 85.68% |
| 2 | Technology | 0.16% |
| 3 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Smith & Nephew
SNN
$16.3B
| – | – | 0 | – | – |
|
127
SPDR S&P 500 ETF Trust
SPY
$658B
| – | – | 0 | – | – |
|
128
Viatris
VTRS
$12.3B
| – | – | 0 | – | – |
|
129
Xoma
XOMA
$392M
| – | – | -2,000,000 | Closed | -$7.18M |
|
|
SGEN
130
DELISTED
Seagen Inc. Common Stock
SGEN
| – | – | 0 | – | – |
|
|
ALBO
131
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| – | – | -209,700 | Closed | -$279K |
|
|
AKRX
132
DELISTED
Akorn, Inc.
AKRX
| – | – | 0 | – | – |
|
|
STJ
133
DELISTED
St Jude Medical
STJ
| – | – | -173,000 | Closed | -$11.3M |
|
|
AEGR
134
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| – | – | 0 | – | – |
|
|
QLTI
135
DELISTED
QLT Inc
QLTI
| – | – | 0 | – | – |
|
|
GEVA
136
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| – | – | -77,800 | Closed | -$7.22M |
|
|
NPSP
137
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| – | – | -2,954,900 | Closed | -$106M |
|
|
COV
138
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| – | – | -211,200 | Closed | -$21.6M |
|
|
AGN
139
DELISTED
ALLERGAN INC
AGN
| – | – | -741,300 | Closed | -$158M |
|